- Insider Monkey•14 days ago
No major moves in the US stock market this Wednesday morning, as investors digest retail earnings reports and are keeping an eye on oil prices. Analysts are expecting the market to be calm over the next few weeks, except for any shocks, as the stocks continue to trade in a tight range. In this article […]
- Associated Press•15 days ago
The San Diego-based company said it had a loss of 21 cents per share. The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for ...
- PR Newswire•15 days ago
SAN DIEGO, Aug. 9, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results and recent highlights for the second quarter ended June 30. "I am very pleased with ...
HALOZYME THERAPEUT (RV7.BE)
Berlin - Berlin Delayed Price. Currency in EUR
As of 2:08 AM EDT. Market open.
|Day's Range||8.77 - 8.77|
|52wk Range||6.93 - 9.31|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||0|
|Dividend & Yield||N/A (N/A)|